SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-034577
Filing Date
2023-10-18
Accepted
2023-10-18 16:00:40
Documents
3
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1697659230.html 3  
1 FORM 3 wk-form3_1697659230.xml 3 1648
2 EX-24 x4pharmaceuticalsinc_poa.htm EX-24 4344
3 x4pharmaceuticalsinc_poa001.jpg GRAPHIC 252687
  Complete submission text file 0001628280-23-034577.txt   355618
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O X4 PHARMACEUTICALS INC. 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address
Woods Keith (Reporting) CIK: 0001996804 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 231332218